Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II trial with clinical outcomes, analysis of serum tumor markers as predictive factors, and cardiac surveillance algorithm (Q44529239)
scientific article published in August 2003
Language:
(P31) (Q13442814)
(P50) (Q109562169)
(Q16887072)
(Q125263555)
(Q125263935)
(P304) 2889-2895
(P407) (Q1860)
(P433) 15
(P478) 21
(P577) Friday, August 1, 2003
(P921) (Q42824440)
(Q6934595)
(Q61643320)
(Q12859063)
(Q412616)
(P1433) (Q400292)
(P1476) "Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II trial with clinical outcomes, analysis of serum tumor markers as predictive factors, and cardiac surveillance algorithm" (language: en)
(P2093) Lyndsay N Harris
P Kelly Marcom
Kathleen Havlin
Beth Overmoyer
Robert J Friedlander
Janet Gargiulo
Rochelle Strenger
Charles L Vogel
Paula D Ryan
Mathew J Ellis
Raquel A Nunes
Susana M Campos
Michele Hallor
Rebecca Gelman
other details
description scientific article published in August 2003

External Links